Ashland Inc. Sells Nutraceuticals Business to Turnspire Capital Partners
WILMINGTON, DE — Ashland Inc. (NYSE: ASH) has finalized the sale of its nutraceuticals division to Turnspire Capital Partners LLC, effective August 30, 2024. This transaction includes custom formulation and contract …
Ashland Inc. Sells Nutraceuticals Business to Turnspire Capital Partners Read More